Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Greenberg

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Seminars in Neurology|February 4, 2010
Pearls: neuromuscular disordersSteven A Greenberg
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2017
Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body MyositisSteven A Greenberg
Neurology|October 12, 2007
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implicationsSteven A Greenberg
Radiology|September 11, 2010
Zinc transmetallation and gadolinium retention after MR imaging: case reportSteven A Greenberg
Current Rheumatology Reports|April 29, 2010
Theories of the pathogenesis of inclusion body myositisSteven A Greenberg
Muscle & Nerve|April 23, 2014
Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utilitySteven A Greenberg
Current Opinion in Neurology|August 15, 2009
Inflammatory myopathies: disease mechanismsSteven A Greenberg
BMC Neurology|November 20, 2002
P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptomsSteven A Greenberg
Brain : a Journal of Neurology|November 7, 2009
Comment on alemtuzumab and inclusion body myositisSteven A Greenberg
Current Sports Medicine Reports|March 4, 2025
Web AlertSteven A Greenberg
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Seminars in Neurology|February 4, 2010
Pearls: neuromuscular disordersSteven A Greenberg
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 21, 2017
Unfounded Claims of Improved Functional Outcomes Attributed to Follistatin Gene Therapy in Inclusion Body MyositisSteven A Greenberg
Neurology|October 12, 2007
Proposed immunologic models of the inflammatory myopathies and potential therapeutic implicationsSteven A Greenberg
Radiology|September 11, 2010
Zinc transmetallation and gadolinium retention after MR imaging: case reportSteven A Greenberg
Current Rheumatology Reports|April 29, 2010
Theories of the pathogenesis of inclusion body myositisSteven A Greenberg
Muscle & Nerve|April 23, 2014
Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utilitySteven A Greenberg
Current Opinion in Neurology|August 15, 2009
Inflammatory myopathies: disease mechanismsSteven A Greenberg
BMC Neurology|November 20, 2002
P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptomsSteven A Greenberg
Brain : a Journal of Neurology|November 7, 2009
Comment on alemtuzumab and inclusion body myositisSteven A Greenberg
Current Sports Medicine Reports|March 4, 2025
Web AlertSteven A Greenberg
Pageof 11